The USA Leads India and China in COVID-19 Testing

The U.S. CDC reported about 385 million RT-PCR diagnostic tests had been performed to confirm SARS-CoV-2 coronavirus infections as of late on April 8, 2021.

Recent data published by Statista on April 6, 2021, indicates the USA leads all other counties in COVID-19 tests processed. The USA is followed by India (250m) and China (160m).

As of April 6, 2021, the U.S. Food and Drug Administration (FDA) announced it had authorized 355 coronavirus diagnostic tests, including 258 molecular tests, 75 antibody tests, and 22 antigen tests during the COVID-19 pandemic.

Furthermore, the FDA had authorized 43 molecular tests for home-collected samples.

The FDA recently published A Closer Look at COVID-19 Diagnostic Testing to offer those who might purchase COVID-19 tests more technical information and resources. The COVID-19 tests most people discuss are RT-PCR, the nasal-swab test that detects viral RNA, and various antibody tests that detect if you have an immune response due to past exposure to the SARS-CoV-2 beta coronavirus.